Conference Coverage

Change in approach advised for treatment-resistant depression


 

REPORTING FROM ANXIETY AND DEPRESSION CONFERENCE 2018


“Core components of the recovery model are remediation of functioning, collaborative restoration of skills and competencies, and active community reconnection by reestablishing a place in the community – and by exploring opportunities for independence and social inclusion,” Dr. Aaronson said.


Looking ahead, it is important for the research paradigm to shift as well. One example would be to establish treatment registries for evaluating treatment effectiveness through something like genetic testing or neuroimaging, Dr. Aaronson said. Studying nonpharmacologic interventions such as diet and exercise also would be beneficial.

Dr. Aaronson has helped with research for Neuronetics, and serves as a consultant for LivaNova, Neuronetics, Alkermes, and Genomind. He also has spoken for Sunovion, Neurocrine, and Otsuka.

Pages

Recommended Reading

Long-term effects of ketamine uncertain
MDedge Internal Medicine
Poor sleep, suicide risk linked in college students
MDedge Internal Medicine
Suicidal behaviors are associated with discordant sexual orientation in teens
MDedge Internal Medicine
Serotonin syndrome warnings magnify its rare probability
MDedge Internal Medicine
Serotonin syndrome risk with triptans and antidepressants ‘very low’
MDedge Internal Medicine
Insomnia, major depressive episode linked in U.S. soldiers
MDedge Internal Medicine
Depression risks identified in women
MDedge Internal Medicine
Consanguineous parentage raises risk of mood disorders, psychoses in offspring
MDedge Internal Medicine
Rosacea tied to physical and psychological comorbidities
MDedge Internal Medicine
Esketamine nasal spray brings fast relief of depressive symptoms
MDedge Internal Medicine